综合双重复制皮肤门更换:同时通过导管管理大动脉和心心门
Hristian Hinkov1,2,3, Chong Bin Lee2,4, Dustin Greve1,2
1Deutsches Herzzentrum der Charité (DHZC), Department of Cardiothoracic and Vascular Surgery, Berlin, Germany.
概括
透导管双植入 (TDVI) 为需要结合主动脉和心心替换的患者提供了安全有效的替代方案,显示出出色的早期结果. 这种最少的侵入性方法减轻了与退行性膜疾病的重复手术相关的风险.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 越来越多的老年人口导致退行性大动脉 (AV) 和心心 (MV) 疾病的发病率更高.
- 结合手术AV和MV替换带有重大风险,特别是在重复手术中.
- 透导管双植入 (TDVI) 是一种新兴的替代方案,可以减轻手术风险.
研究的目的:
- 为了分析一个大型的机构系列的单阶段跨导管双植入 (TDVI).
- 解决关于TDVI的有效性和安全性的有限证据.
- 评估TDVI作为手术复制双替换的替代方案.
主要方法:
- 单一中心对13名患者的回顾性分析,这些患者同时接受过导管大动脉植入 (TAVI) 和过导管心心膜植入 (TMVI).
- 从2018年10月到2024年4月收集的数据.
- 主要终点包括门学术研究联盟-3 (VARC-3) 和门学术研究联盟 (MVARC) 的技术成功,30天的设备成功和早期安全性.
主要成果:
- 在TDVI程序中,技术成功率为100%.
- 零30天死亡率和100%的30天设备成功率和早期安全性.
- 在TDVI后的纽约心脏协会功能类从III到II显著改善.
- 没有报告重大不良事件.
结论:
- 对于需要联合门置换的选定患者来说,TDVI是一种安全有效的选择.
- 这项研究证明了TDVI的可行性,并取得了出色的早期结果.
- 需要进一步的前性多中心研究来确认长期影响和指导方针的纳入.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


